PURPOSE Overtreatment of screen-detected localized prostate cancer (LPC) is an important
public health concern, since the survival benefit of aggressive treatment (surgery or …

Background: Cancer-specific mortality is projected to be only 1% in 15 years in
approximately 75% of patients with screen-detected localized prostate cancer (LPC). Nearly …

Purpose: The COMPARE (COMparing treatment options for ProstAte cancer) study aimed to
evaluate and quantify the trade-offs patients make between different aspects of active …

ABSTRACT BACKGROUND Guidelines recommend against treating localized prostate
cancer (PCa) in men with a greater than 10-year life expectancy. However, physicians have …

Objectives. To determine the accuracy of clinicians' predictions of life expectancy in patients
with localized prostate cancer, when provided with information about age and comorbidity …

PURPOSE: We studied the outcome in patients with early and probably organ confined
prostate cancer who were considered candidates for curative therapy and treated …

A comment on this article appears in" Family physicians could help in predicting life
expectancy without prostate cancer." J Clin Oncol. 2008 Feb 1; 26 (4): 690-1; author reply …

Methods: Seven clinical scenarios were summarized from charts of deceased patients. We
recruited 100 medical professionals to review these scenarios and estimate each patient's …

Purpose: We aimed to develop a clinical decision support tool for clinicians counseling
patients with localized prostate cancer. The tool would provide estimates of patient life …

Purpose: The choice of appropriate management for localized prostate cancer depends in
part on the estimated life expectancy of a man. Little is known about the accuracy of existing …